Health Care & Life Sciences » Healthcare Provision | OncBioMune Pharmaceuticals Inc.

OncBioMune Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
77.90
0.00
0.10
-
-
2.30
Cost of Goods Sold (COGS) incl. D&A
284.00
-
-
1.10
3.70
2.30
Gross Income
206.00
-
-
1.10
3.70
2.30
SG&A Expense
485.90
516.80
160.90
1,802.90
2,459.40
1,775.60
EBIT
705.50
534.20
213.20
1,804.00
2,463.10
1,778
Unusual Expense
456.60
-
279.00
101.50
11,232.80
10,343.50
Non Operating Income/Expense
892.00
-
-
-
-
33.60
Interest Expense
45.80
31.70
40.70
108.10
1,153.10
2,130.80
Pretax Income
315.90
565.90
532.90
2,013.60
14,849.00
6,468.30
Consolidated Net Income
315.90
565.90
532.90
2,013.60
14,849.00
6,468.30
Net Income
315.90
565.90
532.90
2,013.60
14,849.00
6,468.30
Net Income After Extraordinaries
315.90
374.40
642.30
2,013.60
9,184.90
6,468.30
Net Income Available to Common
315.90
757.40
532.90
2,013.60
20,177.70
6,468.30
EPS (Basic)
0.70
1.39
0.94
0.03
0.16
-
Basic Shares Outstanding
448.90
449.60
451.60
58,305.90
128,917.00
233,858.50
EPS (Diluted)
0.70
1.68
0.94
0.03
0.16
-
Diluted Shares Outstanding
448.90
449.60
451.60
58,305.90
128,917.00
531,257.60
EBITDA
619.00
516.80
160.80
1,802.90
2,459.50
1,775.60
Other Operating Expense
13.60
-
-
-
-
-

About OncBioMune Pharmaceuticals

View Profile
Address
11441 Industriplex Boulevard
Baton Rouge Louisiana 70809
United States
Employees -
Website http://www.oncbiomune.com
Updated 07/08/2019
OncBioMune Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its products include vaccines, PA-OBC, and PGT-RC. The company was founded on March 18, 2005 and is headquartered in Baton Rouge, LA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.